ROCKET AF: Positive Results For Xarelto, But A Few Chinks In The Armor
This article was originally published in The Pink Sheet Daily
Executive Summary
Rivaroxaban misses two bleeding safety measures, and debate heats up on whether it showed superior efficacy against warfarin.